Table 2 from CINSARC and Sarculator in Patients with Primary Retroperitoneal Sarcoma: A Combined Analysis of Single-Institution Data and the EORTC-STBSG-62092 Trial (STRASS)

Key Points

MAIN FINDING: The analysis reveals significant baseline characteristics in patients with primary retroperitoneal sarcoma.
KEY EVIDENCE: Data from single-institution sources and the EORTC-STBSG-62092 trial highlight the relevance of CINSARC.
APPROACH: A pooled cohort from various trials was examined to derive insights about treatment outcomes.
SIGNIFICANCE: Understanding baseline characteristics can improve treatment planning and outcomes for sarcoma patients.

We only have this paper's title and publication details.

Combined analysis of CINSARC and Sarculator shows baseline characteristics in patients, indicating treatment outcomes in the EORTC-STBSG-62092 trial.

Baseline characteristics of the pooled cohort stratified by CINSARC.

No takes yet. Share an insight, caveat, or question.

Callegaro et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

Share